title: Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene.
authors.forename: R
authors.initials: R
authors.lastname: Zanardi
authors.forename: F
authors.initials: F
authors.lastname: Benedetti
authors.forename: D
authors.initials: D
authors.lastname: Di Bella
authors.forename: M
authors.initials: M
authors.lastname: Catalano
authors.forename: E
authors.initials: E
authors.lastname: Smeraldi
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D002352:Carrier Proteins / Q000235:genetics*; D003865:Major Depressive Disorder / Q000097:blood / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics*; D026901:Membrane Transport Proteins; D008875:Middle Aged; D009419:Nerve Tissue Proteins; D017374:Paroxetine / Q000097:blood; D011110:Polymorphism, Genetic; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors / Q000097:blood; D016037:Single-Blind Method
chemical_list: D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D017374:Paroxetine; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; C493230:SLC6A4 protein, human